Understanding how meprin proteins contribute to tissue injury
Mechanistic Studies on Meprin Metalloproteases and Meprin-Substrate Interactions in Tissue Injury
This study is looking at how certain proteins called meprin metalloproteases might affect tissue damage in diseases like Alzheimer's and kidney disease, with the hope of finding new ways to help treat these conditions.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | North Carolina Agri & Tech St Univ NIH-funded |
| Lab location | 1 site (Greensboro, United States) |
| Project ID | NIH-11092182 on NIH RePORTER |
What this research studies
This research investigates the role of meprin metalloproteases in tissue injury, particularly in conditions like Alzheimer's disease and kidney disease. By examining how these proteins interact with various substrates, the study aims to uncover the cellular and molecular mechanisms that drive inflammation and fibrosis. The research employs advanced molecular biology techniques and animal models to explore the effects of meprin activity on disease progression, which could lead to new therapeutic strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals suffering from inflammatory diseases, neurodegenerative disorders, or kidney-related conditions.
Not a fit: Patients with non-inflammatory conditions or those not affected by tissue injury may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments for diseases associated with tissue injury, such as Alzheimer's and kidney disease.
How similar studies have performed: Previous research has shown that targeting similar pathways in tissue injury has led to promising therapeutic advancements, indicating potential for success in this area.
Where this research is happening
Greensboro, United States
- North Carolina Agri & Tech St Univ — Greensboro, United States (Active)
Researchers
- Principal investigator: Ongeri, Elimelda Moige — North Carolina Agri & Tech St Univ
- Study coordinator: Ongeri, Elimelda Moige
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.